Home / Pioglitazone / Czechia
CZ ATC A10BG03 · updated 2 Nov 2026
Pioglitazone shortage in Czechia
Is there a Pioglitazone shortage in Czechia?
Yes. As of 2 Nov 2026, 5 Pioglitazone products are reported short in Czechia, the first since 15 Apr 2026. The company estimate for the return is 15 Nov 2026 (latest 28 Feb 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | PIOGLITAZON MYLAN 15MG 15MG TBL NOB 28 | VIATRIS LIMITED, Dublin | 15 Apr 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | PIOGLITAZON MYLAN 30MG 30MG TBL NOB 28 | VIATRIS LIMITED, Dublin | 15 Apr 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | PIOGLITAZON ACTAVIS 45MG 45MG TBL NOB 30 | Teva | 8 Sep 2026 | 15 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | PIOGLITAZON ACTAVIS 15MG 15MG TBL NOB 28 KAL | Teva | 25 Sep 2026 | 28 Feb 2027 | Distribution or logistics Kapacitní/distribuční důvody |
| CZ | PIOGLITAZON ACTAVIS 30MG 30MG TBL NOB 98 KAL | Teva | 19 Oct 2026 | 28 Feb 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.